Skip to content

Follow-up of the PETRA (Pre-Eclampsie TRial Amsterdam) children at puberty: health, neurocognitive abilities, and behaviour

Follow-up of the PETRA (Pre-Eclampsie TRial Amsterdam) children at puberty: health, neurocognitive abilities, and behaviour - Follow-up of the PETRA (Pre-Eclampsie TRial Amsterdam) children at puberty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36864
Enrollment
178
Registered
2013-01-07
Start date
2013-02-21
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloeddruk, puberteitsontwikkeling, neurocognitieve ontwikkeling, gedrag intra uterine growth restriction

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Study group: Children of the PETRA. Control group: Age- and gender matched children born at term (>= 37 weeks gestational age) without growth restriction (>= 2500 grams) (either class mates or family).

Exclusion criteria

Exclusion criteria: Study group: Only children from the PETRA are included. Control group: Children born at a gestational age 1 year difference from corrected age of child in study group).

Design outcomes

Primary

MeasureTime frame
Health development • Height • Weight • Body mass index • Head circumference • Skin fold thickness: triceps, scapula, biceps, and suprailiac thickness • Circumference of mid upper arm, waist and hip • Pubertal development according to Tanner*s stadia, age of menarche • Systolic and diastolic blood pressure (BP) Neurocognitive- and behavioural development • Intellectual development: • Attention • Executive functions • Behaviour according to parents and child

Secondary

MeasureTime frame
Health questionnaire concerning the last 2 years •Health problems; nature of problem; visit/treatment specialist; frequency of visit •Medication: sort medication; frequency •Surgical treatment •Disabilities Family questionnaire •Birth date parents •Parental weight •Parental height •Country of birth •Highest educational level •Current employment •Other members of the family Educational level of the child • National educational achievement test (CITO test); domain scores language (taal), mathematics (rekenen-wiskunde), study abilities (studievaardigheden) and geography (wereld orientate), a total score and a standard score • School advice after CITO test • Current level of education and grade • Extra support at school (rugzakje)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)